Cost-effective cell-based therapies: The CHOP experience

Discover how CHOP is driving innovation in CAR T and HSC gene therapies, while optimizing cost efficiency by watching this inspiring talk where Dr. Stephan Kadauke shares real-world insights into the development of accessible cell-based therapies. This presentation was part of the Miltenyi Biotec anniversary event, a celebration of highlighting the company’s pioneering contributions to clinical cell therapy manufacturing courtesy of the CliniMACS® Plus and CliniMACS Prodigy® Systems.